CN Patent

CN101098690A — 用于血脂治疗的ω-3脂肪酸和脂血异常剂

Assigned to Reliant Pharmaceuticals Inc · Expires 2008-01-02 · 18y expired

What this patent protects

一种通过给药患者施用有效量的脂血异常剂和ω-3脂肪酸来用于血脂治疗的方法和组合物。所述方法采用单次给药或单位剂量的脂血异常剂和ω-3脂肪酸的组合来治疗患有高甘油三酯血症、冠心病(CHD)、血管疾病、动脉硬化病和相关病症的患者，并预防或降低心血管和血管疾病。

USPTO Abstract

一种通过给药患者施用有效量的脂血异常剂和ω-3脂肪酸来用于血脂治疗的方法和组合物。所述方法采用单次给药或单位剂量的脂血异常剂和ω-3脂肪酸的组合来治疗患有高甘油三酯血症、冠心病(CHD)、血管疾病、动脉硬化病和相关病症的患者，并预防或降低心血管和血管疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN101098690A
Jurisdiction
CN
Classification
—
Expires
2008-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Reliant Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.